SCHEMBL950110

SCHEMBL950110

COC(=O)c1ccc(C(=O)C=CN(C)C)cc1

nearest known ligand 0.70

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.70
ALDH1A1 P00352 8/20 0.70
HPGD P15428 2/20 0.70
RAB9A P51151 6/20 0.64
LMNA P02545 6/20 0.64
CYP1A2 P05177 2/20 0.64
CYP2C19 P33261 2/20 0.64
RECQL P46063 2/20 0.64
ALOX12 P18054 1/20 0.64
NPC1 O15118 5/20 0.59
POLB P06746 3/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
HSP90AA1 P07900 2/20 0.59
HTT P42858 2/20 0.59
KMT2A Q03164 2/20 0.57
MEN1 O00255 1/20 0.55
GAA P10253 2/20 0.54
TDP1 Q9NUW8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL950108 1.00 MAPT (0.70) MAPTALDH1A1HPGDRAB9ALMNA
SCHEMBL23251385 0.87 MAPT (0.81) MAPTALDH1A1HPGDRAB9ALMNA
SCHEMBL4256808 0.83 MAPT (0.63) MAPTALDH1A1HPGDRAB9ALMNA
SCHEMBL4256806 0.83 MAPT (0.63) MAPTALDH1A1HPGDRAB9ALMNA
SCHEMBL29419236 0.82 MAPT (1.00) MAPTALDH1A1HPGDRAB9ALMNA
SCHEMBL805340 0.82 MAPT (1.00) MAPTALDH1A1HPGDRAB9ALMNA
SCHEMBL782731 0.82 MAPT (1.00) MAPTALDH1A1HPGDRAB9ALMNA
SCHEMBL4070316 0.81 MAPT (0.60) MAPTALDH1A1HPGDRAB9ALMNA
SCHEMBL4070320 0.81 MAPT (0.60) MAPTALDH1A1HPGDRAB9ALMNA
SCHEMBL13528698 0.79 MAPT (0.58) MAPTALDH1A1RAB9ALMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116240560-A Method for electrochemically synthesizing furoquinone by utilizing microchannel reactor 南京工业大学 2023-06-09 CN disclosed
CN-115874201-A Electric synthesis method of furan quinone 南京工业大学 2023-03-31 CN disclosed
EP-2731430-B1 PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2019-04-03 EP disclosed
US-9440964-B2 Pesticidal compositions and processes related thereto DOW AGROSCIENCES LLC (US) 2016-09-13 US disclosed
US-20160229818-A1 Compounds for Nonsense Suppression, and Methods for Their Use PTC THERAPEUTICS, INC. (US) 2016-08-11 US disclosed
US-9315467-B2 Compounds for nonsense suppression, and methods for their use PTC THERAPEUTICS, INC. (US) 2016-04-19 US disclosed
US-20150196033-A1 PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (IN) 2015-07-16 US disclosed
US-20150197514-A1 PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2015-07-16 US disclosed
US-20130019348-A1 PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO DOW AGROSCIENCES LLC (US) 2013-01-17 US disclosed
US-8304539-B2 Fused heteroaryl modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof BRISTOL-MYERS SQUIBB COMPANY (US) 2012-11-06 US disclosed
US-20090247517-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY IRM LLC (BM) 2009-10-01 US disclosed
EP-1713775-A4 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORP (US) 2009-08-12 EP disclosed
US-20080275062-A1 Chemical Compounds SMITHKLINE BEECHAM CORPORATION 2008-11-06 US disclosed
US-20080119473-A1 Compounds for Nonsense Suppression, and Methods for Their Use PTC THERAPEUTICS, INC. 2008-05-22 US disclosed
EP-1799212-A2 COMPOUNDS FOR NONSENSE SUPPRESSION, AND METHODS FOR THEIR USE PTC Therapeutics, Inc. (US) 2007-06-27 EP disclosed
EP-1713775-A2 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2006-10-25 EP disclosed
WO-2006044505-A2 COMPOUNDS FOR NONSENSE SUPPRESSION, AND METHODS FOR THEIR USE PTC THERAPEUTICS, INC. (US) 2006-04-27 WO disclosed
WO-2005074643-A2 BENZAMIDE COMPOUNDS USEFUL AS ROCK INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2005-08-18 WO disclosed
EP-0784612-A1 UREA DERIVATIVES AND THEIR USE AS ACAT-INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-07-23 EP disclosed
WO-1996010559-A1 UREA DERIVATIVES AND THEIR USE AS ACAT-INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-04-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119473-A1 Compounds for Nonsense Suppression, and Methods for Their Use NSUN2, UPF1, NSUN3 MAPT 3781/4885ALDH1A1 3402/4885HPGD 3698/4885
US-20150196033-A1 PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO ACHE, DDT, CAT MAPT 2932/4885ALDH1A1 278/4885HPGD 2084/4885
US-20150197514-A1 PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO ACHE, DDT, CAT MAPT 2932/4885ALDH1A1 278/4885HPGD 2084/4885
US-20130019348-A1 PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO ACHE, DDT, CAT MAPT 2932/4885ALDH1A1 278/4885HPGD 2084/4885
US-20080275062-A1 Chemical Compounds H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR1, CBR3 MAPT 4842/4885ALDH1A1 1941/4885HPGD 647/4885
US-20160229818-A1 Compounds for Nonsense Suppression, and Methods for Their Use NSUN2, UPF1, NSUN3 MAPT 3781/4885ALDH1A1 3402/4885HPGD 3698/4885
US-20090247517-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF CANNABINOID RECEPTOR 1 ACTIVITY CNR1, CNR2, FAAH MAPT 1780/4885ALDH1A1 2743/4885HPGD 1745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.